Curcugen, a bioavailability-enhanced, water-dispersible curcuminoid complex from DolCas Biotech has achieved self-affirmed GRAS (generally recognized as safe) status.
Curcugen, a bioavailability-enhanced, water-dispersible curcuminoid complex from DolCas Biotech has achieved self-affirmed GRAS (generally recognized as safe) status. The status was determined by an independent panel of scientific experts who concluded that the ingredient meets FDA’s definition of safety when used as an ingredient in yogurt, nutrition bars, smoothies, and other food and beverage products at levels of 40-60 mg per serving.
Concurrently, the panel determined an acceptable daily intake (ADI) of Curcugen at 210 mg/person, day, using Joint FAO/WHO Expert Committee on Food Additives (JECFA) standards. The ADI also falls in line with the 2010 EFSA scientific opinion on the “conservative estimate” for assessing exposure to curcumin. The upper limit for consumption of Curcugen, determined the panel, is 1,400 mg/person/day in the same food formats that meet FDA GRAS requirements. These conclusions were drawn directly from the battery of toxicological studies.
“With the new self-GRAS status in place, we can continue studying the brand and broaden its integration into beverages, food and confectionary, and expand its application to additional categories, including sports nutrition and general wellbeing,” said KG Rao, CEO and President of DolCas Biotech, in a press release.